Emmeatech Celebrates 20 Years of Italian Technology with Vision AR

Founded in L’Aquila, Italy, in 2006, Emmeatech celebrates two decades of innovation with Vision AR, bringing Augmented Reality, Industrial AI and digital transformation to industrial and pharmaceutical processes.

Twenty years of technology, research and innovation applied to industrial processes marks a major milestone for Emmeatech Srl. Founded in L’Aquila in 2006, the Italian technology company is celebrating its 20th anniversary in 2026 with a strategy focused on international growth and the continued development of digital solutions based on Augmented Reality, Industrial AI, Computer Vision, Industrial IoT, automation and industrial software.

At the heart of this technological journey is Vision AR, a solution developed by Emmeatech to digitalise operational procedures, inspections and operator activities while creating a direct connection between people, processes, machines and information systems.

Designed and developed in Italy, Vision AR reflects Emmeatech’s approach to industrial digitalisation, combining digital innovation with engineering expertise to support companies operating in environments where quality, safety, regulatory compliance and traceability are critical.

The company’s focus is particularly relevant to pharmaceutical manufacturing, where the digital transformation of production processes increasingly needs to balance operational efficiency with GMP requirements, data integrity and robust auditability. In the UK, the MHRA highlights data integrity as a fundamental consideration across GxP environments while GMP remains the minimum standard pharmaceutical manufacturers must meet.

Vision AR Brings Digital Information to the Shop Floor

In modern manufacturing environments, digital transformation cannot be limited to information systems, production equipment or enterprise software. It must also extend to the people responsible for carrying out operational activities, inspections, maintenance and procedures every day.

Vision AR was developed with this principle in mind: to bring digital information, instructions and process data directly into the operational environment where activities take place.

Using smart glasses, tablets and industrial devices, the solution supports operators with:

• digital work instructions;
• multimedia content and 3D models;
• step-by-step guided procedures;
• digital evidence collection;
• structured recording of completed activities.

This approach enables traditional paper-based procedures to evolve into interactive, traceable and connected digital workflows that can be integrated with production processes and wider industrial systems.

The technology is intended to help manufacturers standardise operational activities while giving operators access to relevant information at the point where it is needed. For organisations looking to improve manufacturing efficiency and digitalise shop floor operations, this connection between workers, data and production systems can form an important part of a wider Industry 4.0 strategy.

Key application scenarios include:

• digital SOPs;
• line clearance;
• changeover activities;
• quality inspections;
• maintenance;
• operator training;
• field assistance.

Vision AR can also integrate with the wider industrial ecosystem, connecting operator activities with MES, ERP, EBR, automation systems and production databases.

This interoperability is particularly important in manufacturing environments where information is often distributed across multiple systems. Bringing operational data and instructions together can provide a more connected view of production activities while reducing dependence on isolated or paper-based processes.

Pharmaceutical Manufacturing at the Core of the Strategy

Pharmaceutical manufacturing represents a strategic area for the development of Emmeatech’s technologies.

In regulated production environments, quality, safety, process repeatability and data integrity are essential. Digital transformation therefore needs to deliver more than efficiency gains. It must also support control, traceability and the availability of reliable evidence for quality processes and audits.

This is particularly significant in the UK pharmaceutical sector, where MHRA guidance places strong emphasis on GxP data integrity and the reliability of records generated throughout regulated activities.

Vision AR supports the digitalisation of manufacturing activities by transforming procedures and inspections into structured workflows. Operators can:

• receive contextual instructions during activities;
• follow predefined operational sequences;
• record results and checks;
• collect digital evidence;
• contribute to a complete and traceable process history.

The approach creates a digital record of operational activity while helping organisations establish more consistent processes across manufacturing teams.

Digital and automated technologies are already recognised as important enablers for pharmaceutical manufacturing, with UK innovation programmes identifying areas including data integration, AI-driven manufacturing, OEE, automation and Augmented Reality and Virtual Reality for training and workforce development.

From Line Clearance to Quality Control: Applications in Pharma

Among the most relevant application scenarios for Vision AR are quality inspections, line clearance, changeover operations, digital SOPs and operator training.

Quality Inspections and Visual Checks

The integration of Augmented Reality, image acquisition and Computer Vision technologies supports operators during inspection activities.

By providing digital guidance and structured workflows, the technology is designed to improve standardisation while supporting the collection of digital evidence associated with inspection activities.

Computer Vision can also form part of a wider digital manufacturing strategy, helping companies connect visual inspection processes with production data and operational workflows.

Line Clearance and Changeover

Line clearance and changeover activities are critical manufacturing processes where consistent execution and accurate documentation are essential.

Vision AR can guide operators through digital checklists and predefined verification sequences, recording completed activities and reducing reliance on exclusively paper-based procedures.

By providing instructions directly within the operational environment, the system can help operators work through defined steps while creating a structured record of activities performed.

Digital SOPs and Operator Training

Standard operating procedures can be transformed into interactive digital experiences that support workforce training, knowledge transfer and consistent execution of company standards.

Rather than relying solely on conventional documentation, operators can access relevant instructions and multimedia content through digital devices while carrying out activities.

This can also support knowledge transfer in manufacturing environments where experienced personnel hold valuable operational knowledge and organisations need effective ways to transfer that knowledge to new or developing teams.

GMP, Data Integrity and Regulated Environments

Developing technology for pharmaceutical manufacturing requires a strong focus on regulatory and quality requirements.

Emmeatech solutions designed for regulated environments are developed considering key principles relating to:

• Good Manufacturing Practices (GMP);
• Data Integrity;
• user identification and access management;
• operational traceability;
• audit trails;
• electronic records and electronic signatures according to applicable FDA 21 CFR Part 11 requirements.

The objective is to support pharmaceutical companies in introducing new digital operating models while maintaining a strong focus on data reliability, operator accountability and the ability to reconstruct performed activities.

For UK pharmaceutical manufacturers, data integrity remains an important regulatory consideration. The MHRA’s guidance addresses data governance expectations across GxP sectors and highlights the importance of reliable data throughout the pharmaceutical lifecycle.

The development approach also considers GAMP 5 principles, with attention to risk management, documentation, system configuration and support for qualification and validation activities.

The focus on compliance is intended to ensure that digitalisation does not simply replace paper records with electronic interfaces. Instead, it aims to create structured digital processes in which information, actions and evidence can be connected and traced.

From Compliance to Production Performance: Data, AI and OEE

Digitalising procedures represents only one part of the wider manufacturing transformation journey.

By integrating with industrial systems, machines and enterprise platforms, Emmeatech technologies can connect operator activities with production data.

Information relating to:

• process times;
• completed activities;
• quality checks;
• deviations;
• machine downtime;
• changeover operations;

can contribute to a more complete view of manufacturing processes and support industrial performance indicators such as Overall Equipment Effectiveness (OEE).

This connection between operational execution and production data can help manufacturers move beyond compliance-driven digitalisation towards a broader focus on production performance.

Compliance, quality and efficiency can therefore become integrated elements of a single digital transformation strategy.

For pharmaceutical manufacturing in particular, this convergence of digital data, automation and performance measurement reflects the direction of travel towards more connected and data-driven production environments. UK government initiatives have also highlighted OEE, digital data collection, automation and AI as areas capable of supporting pharmaceutical manufacturing productivity.

From Augmented Reality to Industrial AI

Vision AR forms part of a broader technology ecosystem developed by Emmeatech, including:

• Industrial AI;
• Computer Vision;
• Industrial IoT;
• Automation Software;
• Digital Factory Solutions.

The integration of artificial intelligence, vision systems, industrial data and Augmented Reality creates new opportunities for operator support and process optimisation.

The objective is to develop tools capable of transforming industrial data into actionable information that can be made available directly on the shop floor.

This approach is designed to enhance human capabilities rather than replace the role of people in manufacturing processes.

The emphasis on combining AI with human expertise is increasingly relevant as manufacturers move from experimental AI projects towards practical industrial deployment. The UK government’s 2026 Advanced Manufacturing AI Adoption Plan identifies the need to move from AI innovation and pilot projects towards sustained deployment in complex operational environments.

For industrial organisations, this means that technologies such as AI, Computer Vision and Augmented Reality can increasingly be considered as connected elements of a wider digital manufacturing architecture rather than standalone technologies.

Quality and Cybersecurity as Foundations of Innovation

Emmeatech’s technological development is supported by a structured approach focused on quality management and information security.

The company operates through a UNI EN ISO 9001:2015 certified Quality Management System and has established a cybersecurity assessment path through CyberVadis, achieving the Silver Medal for Outstanding Performance.

Quality and cybersecurity are increasingly important considerations when developing technologies for structured industrial organisations and regulated sectors such as pharmaceutical manufacturing.

As manufacturing becomes more connected, digital systems can link production equipment, enterprise platforms, operators and external systems. Protecting these connections and maintaining reliable information therefore form an important part of digital transformation.

For pharmaceutical organisations in particular, the combination of data integrity, cybersecurity and regulatory compliance can be central to establishing confidence in new digital operating models.

2006 to 2026: Twenty Years of Italian Technology

Founded in L’Aquila in 2006, Emmeatech has experienced twenty years of continuous technological evolution, progressively expanding its expertise from software development and industrial automation into Industrial IoT, Augmented Reality, Computer Vision and Artificial Intelligence.

The company’s 20th anniversary represents both a milestone and the beginning of a new phase focused on international growth.

The development of digital technologies for industrial and pharmaceutical applications places Emmeatech within a wider movement towards connected, data-driven manufacturing.

For pharmaceutical manufacturers, this transformation encompasses everything from digital SOPs and operator training to quality inspections, data collection, machine connectivity and AI-enabled analysis.

“Over the past twenty years, technology has changed dramatically, but our mission has remained the same: transforming innovation into practical tools capable of improving the work of companies and the people operating every day on the production floor,” says Davide Coletti CEO at Emmeatech.

“With Vision AR and our Industrial AI technologies, we aim to bring this experience to international markets, with particular attention to the pharmaceutical sector, where innovation, quality, and reliability are key factors.”

The company’s next stage of development will therefore build on two decades of Italian engineering and technology expertise while targeting opportunities in international industrial and pharmaceutical markets.